- 매출 성장률 -0.3% 보관

Samsung C&T Earnings Jump 68.8% YoY: Buy the Dip?

Samsung C&T gets a Buy rating as earnings accelerate: revenue up 19.7% YoY, operating profit up 34.2%, net profit up 68.8%, boosted by AI service pilots; risks are ROE 5.7% and construction volatility.

2026년 10월 27일

English

KG모빌리티 실적 분석과 주가 전망 투자 전략

KG모빌리티는 택시 접점 확대와 전동화 바이퓨얼 전략으로 매출은 늘었지만 영업이익률 0.4%로 이익이 약해 주가는 관망이 유리합니다

2026년 10월 26일

Korean

Samsung Biologics Q2 Earnings Climb – More Upside Than Valuation Signals

Samsung Biologics has Buy consensus and strong results: revenue up 30%, operating profit up 23%, net income up 33%, with margins at 54% gross and 44% operating, while the stock trades below the average target of about 1.97M won.

2026년 10월 01일

English

SK Holdings Stock Rises on 2026 Results: Value Insight

SK Holdings stock is rated Buy; analyst consensus favors upside as Q2 revenue rose 39.9% and operating profit surged 2,387.8%, keeping forward PER low (4.2x) despite rate and supply risks.